Quarterly report pursuant to Section 13 or 15(d)

EARNINGS PER SHARE - Anti-dilutive (Details)

v3.20.1
EARNINGS PER SHARE - Anti-dilutive (Details) - shares
shares in Thousands
 9 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potential common stock equivalents were excluded from the computation of diluted net loss per share 79,070 211,781
Stock options    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potential common stock equivalents were excluded from the computation of diluted net loss per share 48,155 16,868
Warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potential common stock equivalents were excluded from the computation of diluted net loss per share 30,915 46,389
Series AA Preferred Stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potential common stock equivalents were excluded from the computation of diluted net loss per share   148,524